MetaCap

Covista Inc. (CVSA)

NYSE: CVSAReal EstateOther Consumer ServicesUSD

109.13-6.38 (-5.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CVSA stock chart

Technical analysis

Key statistics

All statistics
Ex-dividend date
Nov 30, 2016
52-week range
86.97 – 142.13
Day range
109.02 – 117.87
Volume / Avg
462.79K / 380.21K
Beta
—

52-week range

$86.97$142.13

CVSA stock today

Covista (CVSA) closed at $109.13 on Nov 20, down 5.52% (-$6.38), versus the S&P 500's 3.70% decline. Shares are 23.2% below their 52-week high of $142.13, set on Aug 28, 2026 and 25.5% above the 52-week low of $86.97, in the middle of the past year's range. CVSA is up 5.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 16.9%.

At 13.8x trailing earnings, Covista trades above the peer-group median of 11.6x. Its forward P/E of 10.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Covista

Company profile

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten.

Industry
Other Consumer Services
CEO
Mr. Stephen W. Beard J.D.
Headquarters
Chicago, IL
Employees
4,736

Financial highlights

Full financials

In fiscal 2026, Covista generated $1.95 billion in revenue, up 9.3% from fiscal 2025, its 6th consecutive year of revenue growth. Net income was $251.6 million (+6.1% year over year), for a net margin of 12.9% versus a median of 8.6% in the prior 5 years. Gross margin was 57.3% (up from 56.9%) and operating margin 19.6%.

Covista annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$1.95B$1.79B$1.58B$1.45B$1.38B
Growth+9.27%+12.85%+9.22%+4.99%+53.67%
Net income$251.57M$237.06M$136.78M$93.36M$310.99M
EPS (diluted)$7.04$6.18$3.39$2.05$6.43

Analyst forecast

Forecast

Consensus (4 analysts)

none

Avg. price target

$159.00+45.70%

  • Strong buy 1
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $140.00High $175.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$1.95 vs $1.90
Surprise
+2.63%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.18
Ex-dividend date
Nov 30, 2016

CVSA news

All CVSA news

Covista peers

Real Estate sector
CVSA peer companies
CompanyPrice% ChgMarket capCompare
LRNStride Inc.74.58-2.13%$3.14Bvs CVSA
UNFUnifirst Corporation228.42-0.86%$4.13Bvs CVSA
LAURLaureate Education Inc.32.06-1.32%$4.35Bvs CVSA
LOPEGrand Canyon Education Inc.108.13-2.78%$2.76Bvs CVSA
BFAMBright Horizons Family Solutions Inc.50.15+0.76%$2.40Bvs CVSA
DAOYoudao Inc. ADR17.23-1.88%$2.08Bvs CVSA
GHCGraham Holdings Company1,252.25+0.05%$5.22Bvs CVSA
TALTAL Education Group ADR9.60-4.19%$5.33Bvs CVSA

Indexes, lists and sector

Covista stock FAQ

What is Covista's stock price today?

CVSA last traded at $109.13 as of Nov 20, 4:00 PM EST, down 5.52% on the day. Prices are delayed at least 15 minutes.

Does Covista pay a dividend?

Yes. Covista pays $0.00 per share annually. The most recent dividend of $0.18 had an ex-dividend date of Nov 30, 2016.

What is CVSA's P/E ratio?

CVSA trades at a trailing P/E ratio of 13.78 and a forward P/E of 10.80, compared with a median of 11.6 for its closest peers.

Who is Covista's CEO?

Mr. Stephen W. Beard J.D. is the chief executive officer of Covista Inc., which has about 4,736 employees.

Has CVSA ever split its stock?

Yes. The most recent CVSA stock split was a 2-for-1 split on Jun 22, 1998, one of 3 splits on record.

What is the CVSA 52-week high?

The 52-week high for CVSA is $142.13 and the 52-week low is $86.97. The stock is currently 23.2% below its high.

Compare CVSA